Related Experiment Video
Updated: Sep 27, 2025
08:19
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.1K
Dnmt3a-Mutant Hematopoietic Stem Cell Rewire IFNγ Signaling to Gain Clonal Advantage
Marco De Dominici, James DeGregori1
1Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Blood Cancer Discovery
|April 8, 2022
Abstract
Summary:
Dnmt3a-mutant stem cells gain a competitive advantage via upregulation of a Txnip-p53-p21 axis and protection from IFNγ induced exhaustion. See related article by Zhang et al., p. 220 (5).
Insights
Dnmt3a-mutant stem cells gain a competitive edge by activating a Txnip-p53-p21 pathway. This mechanism protects them from exhaustion caused by interferon-gamma (IFNγ).
Area of Science:
- Stem cell biology
- Cancer research
- Epigenetics
Background:
- DNA methyltransferase 3A (Dnmt3a) mutations are common in hematologic malignancies.
- Understanding the functional consequences of Dnmt3a mutations in stem cells is crucial.
Discussion:
- Dnmt3a mutations promote stem cell competitiveness through a specific molecular axis.
- This axis involves Thioredoxin-interacting protein (Txnip), p53, and p21.
- The pathway confers resistance to interferon-gamma (IFNγ)-induced exhaustion.
Key Insights:
- Upregulation of the Txnip-p53-p21 pathway is a key mechanism for Dnmt3a-mutant stem cell advantage.
- This pathway provides a protective effect against immune-mediated exhaustion.
- Identifies a novel mechanism contributing to clonal hematopoiesis and leukemogenesis.
Outlook:
- Therapeutic strategies could target this axis to control mutant stem cell expansion.
- Further research into the role of Txnip, p53, and p21 in stem cell regulation is warranted.
